H1N1 vaccine associated with small but significant risk of Guillain-Barre syndrome
12:12 EDT 10 Jul 2012 | Medical Xpress
Guillain-Barre syndrome (GBS) is usually characterized by rapidly developing motor weakness and areflexia (the absence of reflexes). "The disease is thought to be autoimmune and triggered by a stimulus of external origin. In 1976-1977, an unusually h..
Original Article: H1N1 vaccine associated with small but significant risk of Guillain-Barre syndrome
More From BioPortfolio on "H1N1 vaccine associated with small but significant risk of Guillain-Barre syndrome"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
